StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.62−0.33 (-6.67%)

Close on Nov 12, 2026Market cap $730.31KP/E –Yield –

Clearmind Medicine statistics

44 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jul 31, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$730.31K
$280.48M
Enterprise Value
-$11.30M
$148.62M

Share statisticsIndustry

Shares Change (YoY)
64.0%
10.9%
Shares Held by Institutions
3.88%
56.4%

Short sellingIndustry

Short Interest
1,160
–
Short Interest Change
-70.0%
-0.76%
Short % of Shares Outstanding
0.73%
6.30%
Days to Cover
1.00
5.13

Stock price statisticsIndustry

52-Week High
$2076.80
–
52-Week Low
$4.62
–
20-Day Moving Average
$5.80
–
50-Day Moving Average
$6.51
–
200-Day Moving Average
$38.69
–
Average True Range (14)
$0.48
–
Price Change (1 Week)
-21.0%
1.51%
Price Change (1 Month)
-26.5%
-2.37%
Price Change (3 Months)
-69.0%
-21.1%
Price Change (6 Months)
-89.1%
-22.8%
Price Change (YTD)
-96.8%
-22.6%
Price Change (1 Year)
-99.7%
-21.0%
Price Change (3 Years)
-100.0%
-24.8%
Price Change (5 Years)
-100.0%
-76.9%
Average Volume (10 Days)
6,613
–
Average Volume (20 Days)
6,794
–
Average Volume (90 Days)
52,714
–
Relative Volume
0.20
0.80
Relative Strength Index (14)
24.9
44.7
Volatility (1 Year)
163.0%
80.2%
Beta (5 Years)
-1.78
1.07

Financial positionIndustry

Current Ratio
4.31
3.31
Quick Ratio
3.12
2.41

EfficiencyIndustry

Employee Count
2
75
WACC
7.38%
10.0%

Income statement (TTM)Industry

Pretax Income
-$3.79M
-$13.23M
EPS (Diluted)
-$30.35
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$12.04M
$16.98M
Net Cash Per Share
$76.14
$0.72
Working Capital
$12.77M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$4.73M
-$12.27M

Taxes and interestIndustry

Interest Expense
$3.86K
$2.97M
Income Tax
$70.45K
$74.00K

Scores and fair valueIndustry

Altman Z-Score
-1.86
0.26

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodCMNDS&P 500DifferenceCMND per yearS&P 500 per year
1 month-29.4%-2.7%−26.7 pts
3 months-65.0%-1.7%−63.3 pts
Year to date-96.8%+11.9%−108.7 pts
1 year-99.5%+12.0%−111.5 pts
3 years-100.0%+78.2%−178.1 pts-92.9%+21.2%
5 years-100.0%+73.2%−173.2 pts-92.3%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M CMND shares were sold short on Oct 30, 2026, down 70.0% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 34.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,160-70.0%7,3711.0
Oct 15, 20263,861-73.9%35,8571.0
Sep 30, 202614,819-58.5%259,6441.0
Sep 15, 202635,733+41.9%1,909,7071.0
Aug 31, 202625,174-48.9%188,9151.0
Aug 14, 202649,268+2.8%112,5101.0
Jul 31, 202647,941-45.6%242,7131.0
Jul 15, 202688,087-56.7%1,322,9691.0
Jun 30, 2026203,361-41.5%824,4801.0
Jun 15, 2026347,793+758.6%3,878,7131.0
May 29, 202640,505-80.3%5,667,1971.0
May 15, 2026205,330-53.0%494,0111.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?